Stoneridge Investment Partners LLC Pfizer Inc Transaction History

Stoneridge Investment Partners LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$25.89 - $29.73 $409,087 - $469,763	15,801 Added 7.09%	238,671 $6.62 Million
Q4 2023 Feb 07, 2024	BUY	$26.13 - $33.94 $3.47 Million - $4.51 Million	132,761 Added 147.33%	222,870 $6.42 Million
Q3 2023 Nov 03, 2023	BUY	$32.09 - $37.51 $2.89 Million - $3.38 Million	90,109 New	90,109 $2.99 Million
Q1 2022 Apr 26, 2022	BUY	$45.75 - $56.69 $863,531 - $1.07 Million	18,875 New	18,875 $977,000
Q4 2020 Feb 02, 2021	SELL	$33.47 - $42.56 $1.58 Million - $2 Million	-47,071 Closed	0 $0
Q3 2020 Oct 28, 2020	SELL	$31.75 - $37.25 $4.37 Million - $5.13 Million	-137,662 Reduced 74.52%	47,071 $1.73 Million
Q2 2020 Aug 05, 2020	BUY	$30.12 - $36.54 $3.46 Million - $4.19 Million	114,801 Added 164.16%	184,733 $6.04 Million
Q1 2020 May 05, 2020	BUY	$27.03 - $38.62 $1.58 Million - $2.26 Million	58,524 Added 513.01%	69,932 $2.28 Million
Q3 2019 Oct 30, 2019	BUY	$32.49 - $42.13 $370,645 - $480,619	11,408 New	11,408 $410,000
Q3 2018 Oct 30, 2018	SELL	$34.47 - $41.81 $322,018 - $390,589	-9,342 Closed	0 $0
Q2 2018 Jul 31, 2018	SELL	$32.98 - $35.16 $3.74 Million - $3.98 Million	-113,326 Reduced 92.38%	9,342 $339,000
Q1 2018 Apr 27, 2018	BUY	$31.91 - $37.02 $3.91 Million - $4.54 Million	122,668 New	122,668 $4.35 Million
Q4 2017 Feb 05, 2018	SELL	$33.26 - $35.29 $339,750 - $360,487	-10,215 Closed	0 $0
Q3 2017 Nov 02, 2017	BUY	$31.0 - $34.15 $316,665 - $348,842	10,215	10,215 $365,000

3,257

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $139B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Stoneridge Investment Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Stoneridge Investment Partners LLC with notifications on news.